Latest Australian Markets News

Lendlease has expanded its Australian development pipeline with a landmark $2.5 billion luxury residential project at 175 Liverpool Street, Sydney, signaling strong confidence in the high-end market and its strategic growth plans.

Finbar Group has signed a conditional contract to sell a key Rivervale site for $13.68 million, paving the way for a large-scale build-to-rent development backed by community housing initiatives.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

The Federal Court of Australia has approved Dollarama’s acquisition of The Reject Shop, setting the stage for a significant shift in the Australian discount retail landscape. Shareholders are poised to receive a special dividend and a cash payout as the scheme becomes effective.

QuickFee Limited has successfully completed an oversubscribed Share Purchase Plan, raising a total of A$1.532 million alongside a recent placement, positioning the fintech for accelerated loan book expansion in the US and Australia.

Collins Foods delivered resilient FY25 results with solid revenue growth and a strategic pivot towards German market expansion, while addressing profitability challenges in the Netherlands.

X2M Connect has secured a $3 million deal to supply 100,000 IoT-connected personal safety devices for Seoul’s 2025 Smart City initiative, with potential to scale to one million units.

Shift4 Payments, LLC has entered into a definitive scheme implementation agreement to acquire Smartpay Holdings Limited at NZ$1.20 per share, subject to regulatory and shareholder approvals. The transaction outlines a detailed timetable and conditions, including Overseas Investment Office consent and court sanction.

Keybridge Capital has lodged formal applications with the Takeovers Panel contesting Yowie Group’s off-market takeover offer, citing alleged legal circumvention and disclosure issues. The dispute raises questions about control dynamics and shareholder rights in the unfolding corporate tussle.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

S&P Dow Jones Indices has announced its June 2025 quarterly rebalance, with notable additions and removals across major S&P/ASX indices effective June 23. These changes reflect evolving market dynamics and could influence investor portfolios.

Empire Energy Group has launched a $28 million equity raise to finance critical development activities in the Beetaloo Basin, targeting first gas sales from its Carpentaria Pilot Project in 2025. The capital raise, combined with a $65 million financing package, underpins the company’s ambition to commercialize one of Australia’s largest low-CO2 shale gas resources.